Closing the Translational Gap in Cardiovascular Artificial Intelligence: From Drug Discovery to Evidence Synthesis.

Biondi-Zoccai G, Frati G, Booz GW

Open source

DOI
10.1097/fjc.0000000000001808
Published
2026 Jun 1
Container
Journal of cardiovascular pharmacology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1097/fjc.0000000000001808,
  title = {Closing the Translational Gap in Cardiovascular Artificial Intelligence: From Drug Discovery to Evidence Synthesis.},
  author = {Biondi-Zoccai G and Frati G and Booz GW},
  year = {2026},
  journal = {Journal of cardiovascular pharmacology},
  doi = {10.1097/fjc.0000000000001808},
  url = {https://doi.org/10.1097/fjc.0000000000001808}
}

RIS

TY  - JOUR
TI  - Closing the Translational Gap in Cardiovascular Artificial Intelligence: From Drug Discovery to Evidence Synthesis.
AU  - Biondi-Zoccai G
AU  - Frati G
AU  - Booz GW
PY  - 2026
JO  - Journal of cardiovascular pharmacology
DO  - 10.1097/fjc.0000000000001808
UR  - https://doi.org/10.1097/fjc.0000000000001808
ER  - 

APA

G, B., G, F., & GW, B. (2026). Closing the Translational Gap in Cardiovascular Artificial Intelligence: From Drug Discovery to Evidence Synthesis.. Journal of cardiovascular pharmacology. https://doi.org/10.1097/fjc.0000000000001808

Source records